295 related articles for article (PubMed ID: 27747010)
1. Clinicopathological characteristics and prognosis of non-lepidic invasive adenocarcinoma presenting as ground glass opacity nodule.
Moon Y; Sung SW; Lee KY; Park JK
J Thorac Dis; 2016 Sep; 8(9):2562-2570. PubMed ID: 27747010
[TBL] [Abstract][Full Text] [Related]
2. The prognosis of invasive adenocarcinoma presenting as ground-glass opacity on chest computed tomography after sublobar resection.
Moon Y; Lee KY; Park JK
J Thorac Dis; 2017 Oct; 9(10):3782-3792. PubMed ID: 29268386
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Factors of Non-Predominant-Lepidic Lung Adenocarcinoma Presenting as Ground Glass Opacity: Results of a Multicenter Study.
Messa F; Siciliani A; Piccioni G; Leonardi B; Ciccone AM; D'Andrilli A; Andreetti C; Menna C; Vanni C; Baccarini AE; Tiracorrendo M; Mancini M; Vecchione A; Nocera A; Calabrese G; Meacci E; Margaritora S; Natale G; Fiorelli A; Venuta F; Rendina EA; Maurizi G; Ibrahim M
J Pers Med; 2024 Jan; 14(2):. PubMed ID: 38392586
[TBL] [Abstract][Full Text] [Related]
4. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma?
Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K
Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638
[TBL] [Abstract][Full Text] [Related]
5. Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma.
Miyoshi T; Aokage K; Katsumata S; Tane K; Ishii G; Tsuboi M
Ann Thorac Surg; 2019 Jul; 108(1):249-255. PubMed ID: 30876742
[TBL] [Abstract][Full Text] [Related]
6. Role of ground-glass opacity in pure invasive and lepidic component in pure solid lung adenocarcinoma for predicting aggressiveness.
Mimae T; Miyata Y; Tsutani Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
JTCVS Open; 2022 Sep; 11():300-316. PubMed ID: 36172403
[TBL] [Abstract][Full Text] [Related]
7. Pathological and radiological T descriptors in invasive lung adenocarcinoma: from correlations to prognostic significance.
Ma Z; Han H; Cao H; Wang S; Li Y; Zhang Y; Chen H
Transl Lung Cancer Res; 2023 Nov; 12(11):2181-2192. PubMed ID: 38090517
[TBL] [Abstract][Full Text] [Related]
8. Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma.
Hattori A; Hirayama S; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
J Thorac Oncol; 2019 Feb; 14(2):265-275. PubMed ID: 30368010
[TBL] [Abstract][Full Text] [Related]
9. Influence of Ground Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non-Small Cell Lung Cancer.
Aokage K; Miyoshi T; Ishii G; Kusumoto M; Nomura S; Katsumata S; Sekihara K; Tane K; Tsuboi M
J Thorac Oncol; 2018 Apr; 13(4):533-542. PubMed ID: 29246833
[TBL] [Abstract][Full Text] [Related]
10. Pathological features and prognostic implications of ground-glass opacity components on computed tomography for clinical stage I lung adenocarcinoma.
Katsumata S; Aokage K; Ishii G; Hoshino H; Suzuki J; Miyoshi T; Tane K; Samejima J; Tsuboi M
Surg Today; 2021 Jul; 51(7):1188-1202. PubMed ID: 33745094
[TBL] [Abstract][Full Text] [Related]
11. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients.
Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875
[TBL] [Abstract][Full Text] [Related]
12. The presence of micropapillary and/or solid subtypes is an independent prognostic factor for patients undergoing curative resection for stage I lung adenocarcinoma with ground-glass opacity.
Li R; Li Z; Yang Z; Qiu B; Tan F; Xue Q; Gao S; He J
Transl Lung Cancer Res; 2024 Feb; 13(2):256-268. PubMed ID: 38496684
[TBL] [Abstract][Full Text] [Related]
13. A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions.
Asamura H; Suzuki K; Watanabe S; Matsuno Y; Maeshima A; Tsuchiya R
Ann Thorac Surg; 2003 Oct; 76(4):1016-22. PubMed ID: 14529977
[TBL] [Abstract][Full Text] [Related]
14. Presence of Even a Small Ground-Glass Component in Lung Adenocarcinoma Predicts Better Survival.
Berry MF; Gao R; Kunder CA; Backhus L; Khuong A; Kadoch M; Leung A; Shrager J
Clin Lung Cancer; 2018 Jan; 19(1):e47-e51. PubMed ID: 28743420
[TBL] [Abstract][Full Text] [Related]
15. Distinct Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer with Radiologic Part-Solid or Solid Lesions.
Fu F; Zhang Y; Wen Z; Zheng D; Gao Z; Han H; Deng L; Wang S; Liu Q; Li Y; Shen L; Shen X; Zhao Y; Zhao Z; Ye T; Xiang J; Zhang Y; Sun Y; Hu H; Chen H
J Thorac Oncol; 2019 Dec; 14(12):2133-2142. PubMed ID: 31437531
[TBL] [Abstract][Full Text] [Related]
16. Correlation in histological subtypes with high resolution computed tomography signatures of early stage lung adenocarcinoma.
Miao Y; Zhang J; Zou J; Zhu Q; Lv T; Song Y
Transl Lung Cancer Res; 2017 Feb; 6(1):14-22. PubMed ID: 28331820
[TBL] [Abstract][Full Text] [Related]
17. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
[TBL] [Abstract][Full Text] [Related]
18. Indications for sublobar resection of clinical stage IA radiologic pure-solid lung adenocarcinoma.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1100-1108. PubMed ID: 28629842
[TBL] [Abstract][Full Text] [Related]
19. [Validation of prognostic value of pathological staging in pathological stage Ⅰ lung adenocarcinoma].
Zhang H; Sun FH; Chen ZC; Wang Q
Zhonghua Wai Ke Za Zhi; 2022 Jun; 60(6):580-586. PubMed ID: 35658346
[No Abstract] [Full Text] [Related]
20. Invasive adenocarcinoma manifesting as pure ground glass nodule with different size: radiological characteristics differ while prognosis remains the same.
Wang Z; Zhu W; Lu Z; Li W; Shi J
Transl Cancer Res; 2021 Jun; 10(6):2755-2766. PubMed ID: 35116586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]